
Company Info
Year Established2017
Contacts
Thomas W. Chalberg, PhD, MBAFounder, Chair & CEO
Company Description
Genascence is a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, is developing life-changing treatments for highly prevalent conditions affecting millions of people.